Table 2 USP1 over/underexpression in several cancer tissue types
Cancer type | Overexpressed | Underexpressed |
|---|---|---|
Sarcoma | 11/15 (73%) | 0/15 (0%) |
Melanoma | 4/6 (67%) | 1/6 (17%) |
Gastric cancer | 5/8 (63%) | 0/8 (0%) |
Cervical cancer | 3/5 (60%) | 0/5 (0%) |
Brain and CNS cancer | 10/20 (50%) | 1/20 (5%) |
Liver cancer | 3/10 (30%) | 0/10 (0%) |
Other cancer | 8/27 (30%) | 6/27 (22%) |
Lung cancer | 4/16 (25%) | 0/16 (0%) |
Bladder cancer | 2/9 (22%) | 0/9 (0%) |
Myeloma | 1/5 (20%) | 0/5 (0%) |
Colorectal cancer | 5/26 (19%) | 0/26 (0%) |
Head and neck cancer | 4/25 (16%) | 0/25 (0%) |
Esophageal cancer | 1/10 (10%) | 0/10 (0%) |
Kidney cancer | 2/20 (10%) | 0/20 (0%) |
Ovarian cancer | 1/11 (9%) | 1/11 (9%) |
Lymphoma | 2/27 (7%) | 3/27 (11%) |
Breast cancer | 1/31 (3%) | 1/31 (3%) |
Leukemia | 0/22 (0%) | 4/22 (18%) |
Pancreatic cancer | 0/8 (0%) | 0/8 (0%) |
Prostate cancer | 0/16 (0%) | 1/16 (6%) |